Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

63
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
63
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

482
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
482

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

USP1 dependent stabilization of LTA4H drives hepatocellular carcinoma angiogenesis.

Biochimica et biophysica acta. Molecular basis of disease·2026
Same author

A positive feedback loop between TKT and c-Myc drives TACE resistance in hepatocellular carcinoma.

Cell death discovery·2026
Same author

USP1 driven mitotic dysregulation and PLK1 stabilization confer Lenvatinib resistance in hepatocellular carcinoma.

Journal of experimental & clinical cancer research : CR·2026
Same author

Dual roles of USP1 in HELLS deubiquitination and SUMOylation drive EMT and FOLFOX-based chemoresistance.

Oncogenesis·2025
Same author

Estrogen Alleviates Myocardial Ischemia-Reperfusion Injury by Inhibiting NLRP3 Inflammasome-Mediated Pyroptosis.

Cardiology research and practice·2025
Same author

Decoding the role of nucleic acid binding protein 2 in lipid dysregulation and hepatocellular carcinoma progression through LKB1-mediated mitochondrial dysfunction.

Cellular signalling·2025

Related Experiment Video

Updated: Aug 16, 2025

A Rat Model of Ventricular Fibrillation and Resuscitation by Conventional Closed-chest Technique
09:47

A Rat Model of Ventricular Fibrillation and Resuscitation by Conventional Closed-chest Technique

Published on: April 26, 2015

15.9K

IVABRADINE-INDUCED HEART RATE REDUCTION INCREASES THE SEVERITY OF POSTRESUSCITATION MYOCARDIAL DYSFUNCTION IN A RAT

Zhangle Hu, Shan Gao1, Jin Yang2

  • 1Department of Pharmacology, Basic Medical College, Anhui Medical University, Hefei, Anhui, China.

Shock (Augusta, Ga.)
|December 22, 2022
PubMed
Summary
This summary is machine-generated.

Reducing heart rate after cardiopulmonary resuscitation (CPR) with ivabradine worsened heart function and survival in rats. This suggests that a rapid heart rate post-CPR may be a beneficial compensatory mechanism.

More Related Videos

A Model of Long-Term Ventricular Fibrillation in Isolated Rat Hearts
07:56

A Model of Long-Term Ventricular Fibrillation in Isolated Rat Hearts

Published on: February 17, 2023

988
Standardized Model of Ventricular Fibrillation and Advanced Cardiac Life Support in Swine
05:36

Standardized Model of Ventricular Fibrillation and Advanced Cardiac Life Support in Swine

Published on: January 30, 2020

7.8K

Related Experiment Videos

Last Updated: Aug 16, 2025

A Rat Model of Ventricular Fibrillation and Resuscitation by Conventional Closed-chest Technique
09:47

A Rat Model of Ventricular Fibrillation and Resuscitation by Conventional Closed-chest Technique

Published on: April 26, 2015

15.9K
A Model of Long-Term Ventricular Fibrillation in Isolated Rat Hearts
07:56

A Model of Long-Term Ventricular Fibrillation in Isolated Rat Hearts

Published on: February 17, 2023

988
Standardized Model of Ventricular Fibrillation and Advanced Cardiac Life Support in Swine
05:36

Standardized Model of Ventricular Fibrillation and Advanced Cardiac Life Support in Swine

Published on: January 30, 2020

7.8K

Area of Science:

  • Cardiovascular Physiology
  • Resuscitation Medicine
  • Pharmacology

Background:

  • Rapid heart rate (HR) post-cardiopulmonary resuscitation (CPR) can be a compensatory mechanism to maintain cardiac output.
  • Sustained tachycardia post-resuscitation may impair myocardial function due to an imbalance in oxygen supply and demand.

Purpose of the Study:

  • To investigate the effect of ivabradine-induced heart rate reduction (HRR) on post-resuscitation myocardial function and survival in a rat model.
  • To determine if inhibiting the sinoatrial node's I f current impacts recovery after CPR.

Main Methods:

  • Male Sprague-Dawley rats underwent 6 minutes of ventricular fibrillation and 8 minutes of CPR.
  • Resuscitated rats were randomized to receive saline or ivabradine (HRR inducer) 1 hour post-resuscitation.
  • Myocardial function, heart rate variability, serum biomarkers (epinephrine, troponin I), and survival duration were assessed.

Main Results:

  • Ivabradine significantly reduced HR compared to saline (P < 0.01).
  • The ivabradine group exhibited significantly worse post-resuscitation myocardial function (P < 0.01) and impaired heart rate variability (P < 0.05).
  • Higher serum troponin I and epinephrine levels and significantly shorter survival duration were observed in the ivabradine group (P < 0.01).

Conclusions:

  • Ivabradine-induced HRR exacerbates post-resuscitation myocardial dysfunction in rats.
  • Reducing heart rate post-CPR with ivabradine is detrimental and shortens survival time.
  • These findings suggest that a rapid heart rate post-CPR might be a necessary compensatory response.